Indian Journal of Medical and Paediatric Oncology

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 40  |  Issue : 4  |  Page : 481--483

Required treatment expenditures for Hepatitis C virus infection and advantage in the reduction of hepatocellular carcinoma incidence: Analysis of possible options in an endemic area


Beuy Joob1, Viroj Wiwanitkit2 
1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India; Department of Tropicla Medicine, Hainan Medical University, Haikou, China; Department of Medical Science, Faculty of Medicine, University of Nis, Niš, Serbia

Correspondence Address:
Dr. Beuy Joob
Sanitation 1 Medical Academic Center, Bangkok
Thailand

Background: Hepatitis C virus (HCV) infection is a known underlying factor contributing to hepatocellular carcinogenesis. The use of direct-acting antiviral (DAA) medication is a form of clinical management for controlling HCV infection and reducing the hepatocellular carcinoma incidence. This medication is introduced to several endemic areas. The big concern is on the treatment expenditures. Several alternative options are proposed and it is required to assess the effect of each alternative option. Objective: Here, the authors assessed and estimated the required treatment expenditures for HCV infection and advantage in the reduction of hepatocellular carcinoma incidence based on the analysis of possible options in an endemic area. Methods: A medical economics analysis was done. Results: According to the cost–utility analysis, the best alternative option that is hereby recommended is DAA medication coverage for all cases. Conclusion: DAA medication coverage for all cases is recommended.


How to cite this article:
Joob B, Wiwanitkit V. Required treatment expenditures for Hepatitis C virus infection and advantage in the reduction of hepatocellular carcinoma incidence: Analysis of possible options in an endemic area.Indian J Med Paediatr Oncol 2019;40:481-483


How to cite this URL:
Joob B, Wiwanitkit V. Required treatment expenditures for Hepatitis C virus infection and advantage in the reduction of hepatocellular carcinoma incidence: Analysis of possible options in an endemic area. Indian J Med Paediatr Oncol [serial online] 2019 [cited 2020 Jun 6 ];40:481-483
Available from: http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=4;spage=481;epage=483;aulast=Joob;type=0